Abstract:Background: Human neutrophil elastase (HNE) is an important contributor to lung diseases such as acute lung injury (ALI) or acute respiratory distress syndrome. Therefore, this study aimed to identify natural HNE inhibitors with anti-inflammatory activity through machine learning algorithms, in vitro assays, molecular dynamic simulation, and an in vivo ALI assay. Methods: Based on the optimized Discovery Studio two-dimensional molecular descriptors, combined with different molecular fingerprints, six machine learning models were established using the Naïve Bayesian (NB) method to identify HNE inhibitors. Subsequently, the optimal model was utilized to screen 6925 drug-like compounds obtained from the Traditional Chinese Medicine Systems Pharmacy Database and Analysis Platform (TCMSP), followed by ADMET analysis. Finally, 10 compounds with reported anti-inflammatory activity were selected to determine their inhibitory activities against HNE in vitro, and the compounds with the best activity were selected for a 100 ns molecular dynamics simulation and its anti-inflammatory effect was evaluated using Poly (I:C)-induced ALI model. Results: The evaluation of the in vitro HNE inhibition efficiency of the 10 selected compounds showed that the flavonoid tricetin had the strongest inhibitory effect on HNE. The molecular dynamics simulation indicated that the binding of tricetin to HNE was relatively stable throughout the simulation. Importantly, in vivo experiments indicated that tricetin treatment substantially improved the Poly (I:C)-induced ALI. Conclusion: The proposed NB model was proved valuable for exploring novel HNE inhibitors, and natural tricetin was screened out as a novel HNE inhibitor, which was confirmed by in vitro and in vivo assays for its inhibitory activities.

Identification and characterization of aptameric inhibitors of human neutrophil elastase

Targeted Library of Phosphonic-Type Inhibitors of Human Neutrophil Elastase

Utilization of computational methods for the identification of new natural inhibitors of human neutrophil elastase in inflammation therapy

Natural Compounds as Inhibitors of Human Neutrophil Elastase

Enzymatic, structural, and biophysical characterization of a single‐domain antibody (VHH) selectively and tightly inhibiting neutrophil elastase and exhibiting favorable developability properties

Non-peptide-based Fluorogenic Small-Molecule Probe for Elastase.

Investigating Polypharmacology Through Targeting Known Human Neutrophil Elastase Inhibitors to Proteinase 3

Studies on Human Neutrophil Elastase and Its Inhibitors

Structure-activity relationships of dihydropyrimidone inhibitors against native and auto-processed human neutrophil elastase

Identification of novel human neutrophil elastase inhibitors from dietary phytochemicals using in silico and in vitro studies

Exploration of novel human neutrophil elastase inhibitors from natural compounds: Virtual screening, in vitro, molecular dynamics simulation and in vivo study

Potential Inhibition of Human Neutrophil Elastase Enzyme to Attenuate Emphysema; A Molecular Docking Study

Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity

Robust anti-inflammatory activity of genistein against neutrophil elastase: a microsecond molecular dynamics simulation study

Peptide Human Neutrophil Elastase Inhibitors from Natural Sources: An Overview

Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling

Characterization of Intra- vs. Extracellular Inhibition

Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α1-antitrypsin-derived peptide motif

Terpenoids as Human Neutrophil Elastase (HNE) Inhibitors: a comprehensive review of Natural Anti‐inflammatory Isoprenoids

Flavonoids as inhibitors of human neutrophil elastase